Correlations of highly-expressed purinergic ligand-gated ion channel 7 purine receptor with clinicopathological features and prognosis in patients with resectable non-small cell lung cancer

DU Xiaodan; XU Weiguo; ZHU Jing; LI Lin; WU Junhua

doi:10.7619/jcmp.20214728

Journal of Clinical Medicine in Practice > 2022 > 26(10): 77-82. > DOI: 10.7619/jcmp.20214728

DU Xiaodan, XU Weiguo, ZHU Jing, LI Lin, WU Junhua. Correlations of highly-expressed purinergic ligand-gated ion channel 7 purine receptor with clinicopathological features and prognosis in patients with resectable non-small cell lung cancer[J]. Journal of Clinical Medicine in Practice, 2022, 26(10): 77-82. DOI: 10.7619/jcmp.20214728

Citation:

PDF (2198 KB)

Correlations of highly-expressed purinergic ligand-gated ion channel 7 purine receptor with clinicopathological features and prognosis in patients with resectable non-small cell lung cancer

Department of Respiratory and Critical Care Medicine, Mianyang Hospital Affiliated to Medical College of University

More Information

Received Date: November 30, 2021
Available Online: May 06, 2022

Graphical Abstract

Abstract

Abstract

Objective
To analyze the correlations of highly-expressed purinergic ligand-gated ion channel 7 purine receptor (P2X7R) with clinicopathological features and prognosis in patients with resectable non-small cell lung cancer (NSCLC).
Methods
A total of 120 specimens of tumor tissue were selected in patients with NSCLC, of which 67 tissue specimens contained adjacent normal lung tissues.The correlation between P2X7R expression and clinicopathological features was analyzed; the Logistic regression model and Kaplan-Meier survival curve were used to evaluate the value of P2X7R expression in predicting the survival and prognosis of NSCLC patients.
Results
The positive expression rate of P2X7R in the NSCLC tissues was significantly higher than that in adjacent normal tissues (P < 0.01);the high expression rate of P2X7R was significantly higher in the NSCLC patients with phase Ⅲ of TNM staging, phase N₁ or N₂ of lymph node status, tumor diameter≥3 cm and low density of CD8⁺ tumour-infiltrating lymphocytes (TILs)(P < 0.05 or P < 0.01);the 5-year disease-free survival and overall survival of patients with low expression of P2X7R were significantly higher than those with high expression of P2X7R (P < 0.01).Cox regression analysis showed that the expression of P2X7R in NSCLC tissues was an independent prognostic influencing factor for 5-year disease-free survival and overall survival (P < 0.05).The areas under the curve of the receiver operating characteristic curve of P2X7R expression in NSCLC tissues for prediction of 5-year recurrence or metastasis and overall survival were 0.850(95%CI, 0.770 to 0.930) and 0.780(95%CI, 0.696 to 0.864) respectively.
Conclusion
P2X7R can be used as a reliable prognostic index and potential therapeutic target for NSCLC.

FullText(HTML)

References (22)

References

[1]	SUN L, ZHOU H B, YANG Y, et al. Meta-analysis of diagnostic and prognostic value of miR-126 in non-small cell lung cancer[J]. Biosci Rep, 2020, 40(5): BSR20200349. doi: 10.1042/BSR20200349
[2]	DING H, WEN W, DING Q Q, et al. Diagnostic valuation of serum miR-184 and miR-191 in patients with non-small-cell lung cancer[J]. Cancer Control, 2020, 27(1): 1073274820964783.
[3]	YE Q, ZHANG M, YIN Y P. Katanin P80 correlates with larger tumor size, lymph node metastasis, and advanced TNM stage and predicts poor prognosis in non-small-cell lung cancer patients[J]. J Clin Lab Anal, 2020, 34(4): e23141.
[4]	李倩倩, 朱晓娣, 赵荣兰, 等. P2X7受体在结肠癌进展中的作用[J]. 国际肿瘤学杂志, 2021, 48(4): 250-253. doi: 10.3760/cma.j.cn371439-20200903-00050
[5]	朱晓娣, 李倩倩, 赵荣兰, 等. P2X7受体与胰腺癌关系的研究进展[J]. 医学研究生学报, 2020, 33(3): 307-311. https://www.cnki.com.cn/Article/CJFDTOTAL-JLYB202003018.htm
[6]	CALIK I, CALIK M, SARIKAYA B, et al. P2X7 receptor as an independent prognostic indicator in gastric cancer[J]. Bosn J Basic Med Sci, 2020, 20(2): 188-196.
[7]	GOEBEL C, LOUDEN C L, MCKENNA R Jr, et al. Diagnosis of non-small cell lung cancer for early stage asymptomatic patients[J]. Cancer Genomics Proteomics, 2019, 16(4): 229-244. doi: 10.21873/cgp.20128
[8]	闫飞, 马艳宁, 宋燕, 等. 多个肿瘤标志物联合检测诊断非小细胞肺癌的价值[J]. 实用临床医药杂志, 2021, 25(9): 14-17. https://www.cnki.com.cn/Article/CJFDTOTAL-XYZL202109004.htm
[9]	吕华伟, 严春霞, 沈冬明. 4种肿瘤标志物联合检测诊断肺癌的价值分析[J]. 实用临床医药杂志, 2020, 24(14): 45-47, 52. https://www.cnki.com.cn/Article/CJFDTOTAL-XYZL202014012.htm
[10]	DU Q, LI E C, LIU Y E, et al. CTAPⅢ/CXCL7: a novel biomarker for early diagnosis of lung cancer[J]. Cancer Med, 2018, 7(2): 325-335. doi: 10.1002/cam4.1292
[11]	DI V F. P2X7 is a cytotoxic receptor receptor… maybe not: implications for cancer[J]. Purinergic Signal, 2021, 17(1): 55-61. doi: 10.1007/s11302-020-09735-w
[12]	GIANNUZZO A, PEDERSEN S F, NOVAK I. The P2X7 receptor regulates cell survival, migration and invasion of pancreatic ductal adenocarcinoma cells[J]. Mol Cancer, 2015, 14: 203. doi: 10.1186/s12943-015-0472-4
[13]	谢玉霜, 包永芬, 陶喆, 等. P2X7受体与疾病的相关性[J]. 生命的化学, 2020, 40(1): 57-63. https://www.cnki.com.cn/Article/CJFDTOTAL-SMHX202001010.htm
[14]	陈永和, 苏宝倡, 尚孟乔. P2X7受体在类风湿关节炎中的诊断价值及炎症反应中的作用[J]. 南方医科大学学报, 2018, 38(12): 1453-1458. https://www.cnki.com.cn/Article/CJFDTOTAL-DYJD201812010.htm
[15]	DE MARCHI E, PEGORARO A, ADINOLFI E. P2X7 receptor in hematological malignancies[J]. Front Cell Dev Biol, 2021, 9: 645605. doi: 10.3389/fcell.2021.645605
[16]	ZHANG Y C, CHENG H, LI W K, et al. Highly-expressed P2X7 receptor promotes growth and metastasis of human HOS/MNNG osteosarcoma cells via PI3K/Akt/GSK3β/β-catenin and mTOR/HIF1α/VEGF signaling[J]. Int J Cancer, 2019, 145(4): 1068-1082. doi: 10.1002/ijc.32207
[17]	CHEN B C, LI H, LIU C, et al. Prognostic value of the common tumour-infiltrating lymphocyte subtypes for patients with non-small cell lung cancer: a meta-analysis[J]. PLoS One, 2020, 15(11): e0242173. doi: 10.1371/journal.pone.0242173
[18]	BOLDRINI L, GIORDANO M, AL G, et al. P2X7 mRNA expression in non-small cell lung cancer: microRNA regulation and prognostic value[J]. Oncol Lett, 2015, 9(1): 449-453. doi: 10.3892/ol.2014.2620
[19]	吴丹, 耿爽, 胡轶. P2X7受体在非小细胞肺癌中的表达及其临床意义[J]. 中国现代医学杂志, 2020, 30(22): 19-24. doi: 10.3969/j.issn.1005-8982.2020.22.004
[20]	QIN J L, ZHANG X Y, TAN B H, et al. Blocking P2X7-mediated macrophage polarization overcomes treatment resistance in lung cancer[J]. Cancer Immunol Res, 2020, 8(11): 1426-1439.
[21]	SALAHUDDIN M M, OMRAN G A, HELMY M W, et al. Effect of regorafenib on P2X7 receptor expression and different oncogenic signaling pathways in a human breast cancer cell line: a potential of new insight of the antitumor effects of regorafenib[J]. Curr Issues Mol Biol, 2021, 43(3): 2199-2209. doi: 10.3390/cimb43030154
[22]	YIN C C, SHEN W H, ZHANG M M, et al. Inhibitory effects of palmatine on P2X7 receptor expression in trigeminal ganglion and facial pain in trigeminal neuralgia rats[J]. Front Cell Neurosci, 2021, 15: 672022. doi: 10.3389/fncel.2021.672022

[1]	PU Meizhi, FENG Xiaoke, XIE Liqun. Mechanism of Xiaochaihutang in treating gastroesophageal reflux disease with insomnia based on network pharmacology[J]. Journal of Clinical Medicine in Practice, 2023, 27(9): 111-118. DOI: 10.7619/jcmp.20230405
[2]	CAI Chuanyun, JIANG Wei, HU Xin. Research progress in treatment of chronic insomnia in the elderly[J]. Journal of Clinical Medicine in Practice, 2023, 27(3): 140-143,148. DOI: 10.7619/jcmp.20222374
[3]	LI Jia, WANG Lin, LIU Nan, WANG Ting, ZHAO Xiaoya, GAO Lini, ZHAO Ping. Effect of mindfulness training on sleep quality and psychological state of perimenopausal patients with insomnia[J]. Journal of Clinical Medicine in Practice, 2022, 26(23): 85-88. DOI: 10.7619/jcmp.20222790
[4]	SHI Yan, WANG Yuanyuan, LIU Xuedong, BAI Ya, MA Lei, LI Wen. Effect of sleep restriction therapy in patients with insomnia disorder comorbid to Parkinson's disease[J]. Journal of Clinical Medicine in Practice, 2021, 25(23): 49-52. DOI: 10.7619/jcmp.20214395
[5]	ZHANG Lei, LIU Yanwei, BAO Qingxia, FENG Guoqin. Effect of auricular acupoint seed-embedding combined with Limian Plaster on long-term improvement of insomnia in patients with advanced cancer[J]. Journal of Clinical Medicine in Practice, 2021, 25(8): 64-66. DOI: 10.7619/jcmp.20210024
[6]	XUAN Jianzong, FENG Xingwen, WU Liangliang, LIU Yuan. Effect observation of Guipi Decoction combined with auricular pressing with pills in treatment of hemodialysis patients with insomnia[J]. Journal of Clinical Medicine in Practice, 2021, 25(7): 59-62. DOI: 10.7619/jcmp.20210328
[7]	ZHU Jinya, LI Yuhua. Effect of exercise therapy in treatment of patients with chronic schizophrenia accompanied by insomnia[J]. Journal of Clinical Medicine in Practice, 2020, 24(24): 57-60. DOI: 10.7619/jcmp.202024017
[8]	CAO Yin, GAO Yanfei, ZHANG Qiaoyang, ZHANG Yi. Effect of cognitive behavioral therapy for insomnia in esophageal cancer patients with insomnia[J]. Journal of Clinical Medicine in Practice, 2019, 23(10): 22-24,28. DOI: 10.7619/jcmp.201910007
[9]	HU Wenzhe, ZHANG Bo. Effect of psychological intervention for insomnia patients with traumatic brain injury in rehabilitation period[J]. Journal of Clinical Medicine in Practice, 2018, (8): 1-3. DOI: 10.7619/jcmp.201808001
[10]	GAO Lini. Effect of nursing intervention on quality of sleep and quality of life in perimenopausal women with insomnia[J]. Journal of Clinical Medicine in Practice, 2015, (18): 78-80. DOI: 10.7619/jcmp.201518025

Cited By

Cited by

Periodical cited type(5)

1.	洪玫，段宏宪，杨敏. 清肝化湿活血汤联合复方甘草酸苷片治疗酒精性肝病的临床疗效及对患者肝功能的影响. 医药论坛杂志. 2023(02): 87-89+93 .
2.	王箭焱. 舒肝宁注射液联合复方甘草酸苷对非酒精性脂肪性肝炎患者脂代谢、肝功能的影响. 中国医学创新. 2023(22): 45-48 .
3.	陈凯，孟祥林. 多烯磷脂酰胆碱注射液对自身免疫性肝炎患者肝功能指标的影响. 中国药物与临床. 2023(10): 665-669 .
4.	罗萍，蒋玲，刘杨武. 甘草酸制剂治疗病毒性肝炎的效果观察. 继续医学教育. 2022(04): 145-148 .
5.	李斌，王磊. 舒肝消癖颗粒联合复方甘草酸苷片治疗非酒精性脂肪肝的临床效果及对肝功能的影响. 反射疗法与康复医学. 2022(07): 8-10 .

Other cited types(1)

Get Citation

PDF

XML

Article views PDF downloads Cited by(6)

Turn off MathJax

Article Contents

Abstract

References

Correlations of highly-expressed purinergic ligand-gated ion channel 7 purine receptor with clinicopathological features and prognosis in patients with resectable non-small cell lung cancer